Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Decrease of Coronary Heart Disease Risk With GLP1-Receptor Agonists or SGLT2 Inhibitors Therapy in Patients With Type 2 Diabetes in Primary Cardiovascular Prevention: A 24 Months Follow-Up StudyDiabetes Res. Clin. Pract. 2021 Jan 28;[EPub Ahead of Print], L D'Onofrio, C Mignogna, A Carlone, E Bellizzi, M Di Guida, C Moretti, S Zampetti, G Leto, E Maddaloni, R Buzzetti
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.